BridgeBio Pharma, Inc. (BBIO)
NASDAQ·Healthcare·Biotechnology
$66.88
-0.99%
Mkt Cap $13.20B
Analyst Ratings
Buy
20
Hold
0
Sell
0
Price Target (37 analysts)
$99.86
Range $83.00 – $157.00
Implied Upside
+49.3%
Consensus $99.86 vs current $66.88
NASDAQ·Healthcare·Biotechnology
$66.88
-0.99%
Mkt Cap $13.20B
Buy
20
Hold
0
Sell
0
Price Target (37 analysts)
$99.86
Range $83.00 – $157.00
+49.3%
Consensus $99.86 vs current $66.88